Formycon AG (LON: 0W4N)
London
· Delayed Price · Currency is GBP · Price in EUR
55.00
-0.40 (-0.72%)
Jan 23, 2025, 11:52 AM BST
Formycon AG Revenue
Formycon AG had revenue of 26.89M EUR in the half year ending June 30, 2024, with 52.42% growth. This brings the company's revenue in the last twelve months to 60.80M, down -11.42% year-over-year. In the year 2023, Formycon AG had annual revenue of 77.70M with 82.83% growth.
Revenue (ttm)
60.80M EUR
Revenue Growth
-11.42%
P/S Ratio
n/a
Revenue / Employee
255.46K EUR
Employees
238
Market Cap
822.77M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 77.70M | 35.20M | 82.83% |
Dec 31, 2022 | 42.50M | 5.88M | 16.07% |
Dec 31, 2021 | 36.61M | 2.32M | 6.76% |
Dec 31, 2020 | 34.30M | 1.14M | 3.43% |
Dec 31, 2019 | 33.16M | -9.84M | -22.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |